NuvaRingŽ: Terms of use

Schering Corporation invites residents of the United States to access and use this Internet site subject to the terms and conditions below and all applicable laws. This site and all information contained therein are intended for access and use by such residents only.

You may download and retain on your disk or in hard copy form a single copy of material published on this site for your personal use, provided that you do not remove any proprietary notices. You may not otherwise copy, distribute, display, download, modify, or repost all or part of any material without Schering Corporation's written permission. You may not mirror on another Web server all or part of any material published by Schering Corporation on this site, and you may not inline any of the graphics contained in any material published on this site.

Schering Corporation will use reasonable efforts to include accurate and up-to-date information on this site, but makes no representations or warranties as to its accuracy or completeness. Access to and use of the content is at your own risk, and neither Schering Corporation nor any party involved in creating or delivering this site shall be liable to you for any damage of any kind arising out of your access, use or inability to access or use this site, or for any omissions or errors in its content.

Schering Corporation reserves the right to alter or delete material from this site at any time.

Schering Corporation may revise these terms and conditions periodically.

Prescription NuvaRing^Ž is a flexible vaginal ring approved for the prevention of pregnancy in women.

For additional important information, please see the FULL PRODUCT INFORMATION, INCLUDING BOXED WARNING.

IMPORTANT SAFETY INFORMATION:

The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, which may lead to stroke or heart attack. NuvaRing^Ž is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing^Ž than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing^Ž use than with the use of certain birth control pills
Cigarette smoking increases the risk of serious cardiovascular side effects, especially in women over 35; women who use combination hormonal contraceptives, including NuvaRing^Ž, are strongly advised not to smoke
NuvaRing^Ž is not for women with certain cancers or those who may be pregnant. NuvaRing^Ž does not protect against HIV infection and other sexually transmitted diseases
The most common side effects reported by NuvaRing^Ž users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Learn more about NuvaRing^Ž: 1-877-NUVARING

This site is intended for U.S. residents.

Terms of Use